Atlas Trials

KRAS/NRAS Mutation

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch KRAS/NRAS Mutation

RecordFirmDate
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation (NCT06106308)Cardiff Oncology2024-02-27

Track KRAS/NRAS Mutation automatically

Every clearance here is in the API, with alerts when new ones post.